Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 295

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 295
---
arrants, ParentCo Common Stock or ParentCo warrants.

<div align='center'>147</div>

TABLE OF CONTENTS

COMPARISON OF STOCKHOLDERS’ RIGHTS The following is a comparison of certain rights of Iris stockholders to the rights of ParentCo stockholders that will be in effect upon the consummation of the Business Combination. These differences arise from the governing documents of the two companies, including the Iris Certificate of Incorporation, as amended and Iris’s Amended and Restated Bylaws and the ParentCo Certificate of Incorporation and ParentCo’s amended and restated bylaws. Unless otherwise stated or unless the context otherwise requires, for the purposes of this section, “Iris Certificate of Incorporation” shall refer to the Iris Certificate of Incorporation, as amended, “Iris bylaws” shall refer to Iris’s amended and restated bylaws, “Proposed ParentCo Certificate of Incorporation” will refer to the proposed ParentCo Certificate of Incorporation, and “Proposed Bylaws” will refer to the proposed ParentCo’s amended and restated bylaws. The summary set out below is not intended to provide a comprehensive discussion of each company’s governing documents. This summary is qualified in its entirety by reference to the full text of each of the Iris Certificate of Incorporation, Iris’s bylaws, the Proposed ParentCo Certificate of Incorporation and the Proposed Bylaws. See the section entitled “ Where You Can Find More Information ” in this proxy statement/ prospectus, for information on how to obtain a copy of these documents. A copy of the ParentCo Certificate of Incorporation is attached as Annex C to this proxy statement/prospectus.

| ​ | ParentCo (the “Surviving Corporation”)                                                                                                                                                                                                      | ​ | ​ | Iris                                                                                                                                                                                                                                                                                                                                                                                                  | ​ |
| ​ | Authorized Capital Stock                                                                                                                                                                                                                    |   |   |                                                                                                                                                                                                                                                                                                                                                                                                       | ​ |
| ​ | The total number of shares of all classes of capital stock which the Surviving Corporation has authority to issue is 500,000,000 shares consisting of:                                                                                      
 (i)                                                                                                                                                                                                                                         
 500,000,000 shares of common stock, par value $0.0001 per share; and                                                                                                                                                                        
 ​                                                                                                                                                                                                                                           
 (ii)                                                                                                                                                                                                                                        
 1,000,000 shares of preferred stock, par value $0.0001 per share.                                                                                                                                                                           
 ​                                                                                                                                                                                                                                           | ​ | ​ | Iris is authorized to issue 301,000,000 shares, consisting of: